Wells Fargo & Company MN Sells 52,025 Shares of Doximity, Inc. (NASDAQ:DOCS)

Wells Fargo & Company MN reduced its position in Doximity, Inc. (NASDAQ:DOCSFree Report) by 13.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 332,837 shares of the company’s stock after selling 52,025 shares during the quarter. Wells Fargo & Company MN owned approximately 0.18% of Doximity worth $9,333,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of DOCS. Vanguard Group Inc. lifted its holdings in shares of Doximity by 5.9% during the 3rd quarter. Vanguard Group Inc. now owns 11,038,475 shares of the company’s stock worth $234,236,000 after acquiring an additional 616,157 shares during the period. Baillie Gifford & Co. lifted its stake in Doximity by 0.9% during the third quarter. Baillie Gifford & Co. now owns 6,656,242 shares of the company’s stock worth $141,245,000 after purchasing an additional 57,078 shares during the period. Norges Bank acquired a new stake in Doximity during the fourth quarter valued at approximately $35,995,000. Charles Schwab Investment Management Inc. grew its stake in shares of Doximity by 10.7% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 699,066 shares of the company’s stock valued at $14,834,000 after purchasing an additional 67,363 shares during the period. Finally, AQR Capital Management LLC raised its holdings in shares of Doximity by 344.2% in the 3rd quarter. AQR Capital Management LLC now owns 540,126 shares of the company’s stock worth $11,461,000 after buying an additional 418,523 shares in the last quarter. Institutional investors and hedge funds own 87.19% of the company’s stock.

Insider Buying and Selling

In other Doximity news, Director Kira Scherer Wampler sold 2,500 shares of the firm’s stock in a transaction that occurred on Friday, May 17th. The shares were sold at an average price of $27.22, for a total value of $68,050.00. Following the transaction, the director now directly owns 10,258 shares of the company’s stock, valued at $279,222.76. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. In related news, Director Kira Scherer Wampler sold 2,500 shares of the company’s stock in a transaction dated Friday, May 17th. The stock was sold at an average price of $27.22, for a total value of $68,050.00. Following the completion of the sale, the director now owns 10,258 shares in the company, valued at $279,222.76. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Craig Overpeck sold 1,500 shares of the firm’s stock in a transaction dated Thursday, May 16th. The stock was sold at an average price of $23.85, for a total value of $35,775.00. Following the transaction, the insider now owns 108,609 shares in the company, valued at approximately $2,590,324.65. The disclosure for this sale can be found here. Insiders sold a total of 6,500 shares of company stock valued at $171,250 over the last ninety days. Insiders own 39.40% of the company’s stock.

Doximity Trading Up 0.3 %

Doximity stock opened at $27.72 on Wednesday. The company has a market cap of $5.14 billion, a PE ratio of 38.50, a PEG ratio of 5.23 and a beta of 1.23. Doximity, Inc. has a 1 year low of $19.71 and a 1 year high of $36.29. The company’s 50-day moving average is $25.71 and its two-hundred day moving average is $26.94.

Analyst Upgrades and Downgrades

A number of brokerages have weighed in on DOCS. Needham & Company LLC reiterated a “hold” rating on shares of Doximity in a research report on Friday, May 17th. SVB Leerink assumed coverage on shares of Doximity in a report on Monday, February 26th. They set a “market perform” rating and a $32.00 price target for the company. William Blair reaffirmed an “outperform” rating on shares of Doximity in a research note on Friday, May 17th. Evercore ISI lifted their target price on shares of Doximity from $28.00 to $29.00 and gave the company an “in-line” rating in a research note on Friday, May 17th. Finally, Wells Fargo & Company increased their price target on Doximity from $25.00 to $27.00 and gave the stock an “equal weight” rating in a research report on Friday, February 9th. One equities research analyst has rated the stock with a sell rating, eleven have assigned a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $28.73.

Get Our Latest Analysis on Doximity

Doximity Company Profile

(Free Report)

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.

Further Reading

Institutional Ownership by Quarter for Doximity (NASDAQ:DOCS)

Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.